Evaluation of S-600918 in Adults With Refractory Chronic Cough

Completed · Phase 2 · Has a placebo group

Conditions studied: Chronic Cough

In brief

The primary objective of this study is to determine the optimal dose of S-600918 in patients with refractory chronic cough by evaluating the change from baseline in 24-hour cough frequency (coughs per hour) with S-600918 compared with placebo.

Key facts

Study ID
NCT04110054
Run by
Shionogi
People needed
406
Starts
2020-02-13
Expected to finish
2020-12-28
Last updated by the study team
2024-03-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.